Michael Donovan

Michael J.
Donovan is the founder of PreciseDx, Inc. since 2021, holding the title of Chief Medical Officer.
Current jobs include Professor, Director-Biorepository & Pathology at Icahn School of Medicine at Mount Sinai since 2011, Chief Medical Officer at LungLife AI, Inc., Executive Vice President at Houston Casualty Co., Professor at the University of Miami, and Chief Medical Officer at Renalytix Plc since 2018.
Former jobs include Senior Director-Molecular Pathology at Millennium Pharmaceuticals, Inc., Senior Vice President at Incyte Corp., Senior Vice President-Research Collaborations at Aureon Biosciences, Inc., Principal at Harvard Medical School, Chief Medical Officer at Exosome Diagnostics, Inc., Chief Medical Officer at MetaStat, Inc., Chief Clinical Officer at Vigilant Biosciences, Inc., and Chief Medical Officer at Verici Dx Plc.
Education includes a doctorate from the University of Medicine & Dentistry of New Jersey and undergraduate, graduate, and doctorate degrees from Rutgers State University of New Jersey.